ResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 6,000-strong team is committed to creating the world's best tech-driven medical device company - improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 120 countries.
ResMed
Venture CapitalResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases.
Founded 1989
San Diego, United States
5k-10k employees
Biotechnology, Digital Health +4
San Diego, United States
5k-10k employees
Biotechnology, Digital Health +4
6
Total Investments
6
Portfolio Companies
-
Exits
6
Industries
General Information
Industries
Biotechnology, Digital Health +4
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About ResMed
Recent Investments (6)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jan 2024 | |
| Venture Round | •••••• | Jan 2023 | |
| Seed Round | •••••• | Apr 2022 | |
| Non Equity Assistance | •••••• | Mar 2022 | |
| Grant | •••••• | Mar 2021 | |
•••• ••••
|
Corporate Round | •••••• | Feb 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
